Search results for: Health Care Systems
Filter search results
Benchmarking and Incentives in the NHS
5 January 2000
…the application of benchmarking in the UK National Health Service (NHS). A key… propper-article Carol Propper This paper examines general issues in the use of benchmarking as a measure of…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
…R&D that serve all consumers. The potential for price differences within the EU arises because health care is a national policy prerogative and different countries have pursued very different regulatory…
Reducing Harm to Patients in the National Health Service. Will the Government’s Compensation Proposals Help?
1 December 2003
The UK government hopes that the proposals in the report of the Department of Health’s Chief Medical Officer “Making Amends” (CMO, 2003) will make its NHS safer whilst ensuring that…
Luigi Siciliani
24 May 2023
…economics. Luigi is affiliated with the Centre for Health Economics and the Economics of Health and Social Care Research Unit. Prior to joining the University of York in 2003, he…
Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS
1 August 2018
…growth in Government funded healthcare expenditure in the UK of 4.0% whilst NHS Digital reported medicines expenditure growth for the English National Health Service (NHS) for the same period at…
NICE at 25: HTA Methods Guidelines – Evolution, not revolution
1 May 2024
…health inequalities in health technology evaluations. NICE has done some research in the health inequalities space, but NICE’s position does not currently allow for a quantitative modifier for health inequalities…
Thomas Allvin
19 March 2024
Thomas Allvin is Executive Director for Strategy and Healthcare Systems at the European Federation of Pharmaceutical Industries and Associations (EFPIA), where his responsibilities include overall strategic coordination, support to the…
Helen Hayes
2 June 2023
…supply side factors of health: payment systems, waiting times, healthcare utilisation, the working lives of GPs, and links between labour market outcomes and health. Her recent research interests have focused…
Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology
1 February 2021
…more than two drugs in the combination regimen, and HTA systems that use different measures of health gain to assess value and therefore price (i.e. for QALY or non-QALY based…